Kelsey Moody of Ichor Therapeutics presented on the LysoClear development program at the Ending Age-Related Diseases conference organized by the Life Extension Advocacy Foundation earlier this year. LysoClear is an example of the commercial development of a rejuvenation therapy, taken all the way from the starting point of the discovery of microbial enzymes capable of breaking down certain forms of harmful age-related molecular waste that contribute to aging and age-related diseases. The actual research is largely done, and the task now is to focus on manufacture, regulatory approval, and entry into the clinic. Taken end to end, I think that this development program might be able to lay claim to being the first and oldest of the modern rejuvenation research initiatives, starting sometime back
From https://jamesjohnson10.blogspot.com/2019/10/kelsey-moody-presenting-on-lysoclear.html
From https://richardwood1.blogspot.com/2019/10/kelsey-moody-presenting-on-lysoclear.html
from
https://richardwood1.wordpress.com/2019/10/15/kelsey-moody-presenting-on-the-lysoclear-program-at-ending-age-related-diseases-2019/
No comments:
Post a Comment